Which peptides are in this family?
-
Afamelanotide
Synthetic alpha-MSH analogue studied in erythropoietic protoporphyria (EPP). Licensed in the UK for adults with EPP; not recommended for routine NHS use. Not the same as Melanotan II.
ModerateLicensed UK medicine -
Melanotan IIMT-II
Synthetic melanocortin receptor agonist studied for skin tanning. Not licensed in the UK; human evidence is a three-volunteer pilot plus case reports.
LimitedNot licensed in the UK -
PT-141 (Bremelanotide)Bremelanotide
No UK marketing authorisation found; authorised in the US. Selective melanocortin-4 receptor agonist studied for low sexual desire in women.
StrongNot licensed in the UK -
Setmelanotide
Synthetic peptide that activates the MC4 receptor, studied in rare forms of obesity. UK prescription-only medicine for three rare conditions; trials were small and do not cover common obesity.
ModerateLicensed UK medicine
Best recorded finding for each peptide in this family
Each row grades one recorded finding, not the peptide or the medicine.
| Peptide | UK status | Finding | Evidence grade |
|---|---|---|---|
| Afamelanotide | Licensed UK medicine | Two phase 3 trials in EPP | Moderate |
| Melanotan II | Not licensed in the UK | Naevi and melanoma case reports | Limited |
| PT-141 (Bremelanotide) | Not licensed in the UK | The RECONNECT Phase 3 trials | Strong |
| Setmelanotide | Licensed UK medicine | Acquired hypothalamic obesity | Moderate |
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.